Although it may seem obvious to patients and caregivers in the cancer community, depression is often a problem that is left untreated, put on the “back burner” to concentrate on the physical aspects of [...]
Advanced Melanoma patients are now able to take a powerful new immuno-cology drug from Merck called Keytruda.
There are many ways to make a difference in the life of a cancer patient. We've put together four that can help make a cancer patient's day.
Comprehensive resources for cancer patients and caregivers can be found on Patient Resource’s website. This is valuable information, not only for GIST patients, but also for those who may have friends and loved ones with other diagnoses.
A new cancer classification system that supports the idea of personalized medicine has been found as a result of a research study by University of California, San Francisco, indicated that more accurate diagnoses could be made based on genetic makeup.
All relationships have to weather storms, but when a couple faces the challenges of cancer treatment, intimacy can suffer. Intimacy can be difficult for any couple, but cancer and intimacy can be an even larger obstacle.
A recent study from the Annals of Surgical Oncology (August, 2014) analyzes data found in the GIST registry conducted by the Kinki GIST Study Group in Japan. It was determined that by identifying asymptomatic patients, the Japanese gastric cancer screening system contributed to early detection of gastric GIST and favorable treatment outcomes.
The Life Raft Group, in partnership with the National Institutes of Health, is pleased to announce that applications are currently being accepted for the second meeting of the NIH-LRG Virtual GIST Tumor Board.
A recent article in Woman’s Day provides valuable insight into how to reach out to someone when you learn they have been diagnosed with cancer. Here's a list of ten things you should never say to a cancer patient.
The European Commission recently announced that Stivarga (regorafenib) from Bayer has been approved in the European Union (EU) as a third line treatment for GIST.
